论文部分内容阅读
作为日本第三大制药公司的山之内,非常看重中国市场,早在80年代就开始对华业务,主要向中国出口成品和原材料并进行一些技术合作。90年代山之内集团开始对华投资,在投资前,山之内对中国各地的投资环境进行了大量的调查,当时辽宁省沈阳市政府对山之内项目推进给予了大力的协助和迅速的反应。通过洽谈,1994年10月山之内和沈阳第一制药厂以合资的形式建厂成立沈阳山之内制药有限公司,项目投资总额3526万美元,共有员工352人。主要生产经营哈乐、高
Yamanouchi, Japan’s third-largest pharmaceutical company, places great emphasis on the Chinese market and started its business with China back in the 1980s, mainly exporting finished products and raw materials to China and undertaking some technical cooperation. In the 1990s, Yamanouchi Group began to invest in China. Prior to its investment, Yamanouchi conducted extensive surveys on the investment environment in various parts of China. At that time, the Shenyang Municipal Government of Liaoning Province gave strong assistance and prompt response to the project within Yamanashi. Through negotiation, in October 1994, Yamanouchi and Shenyang No. 1 Pharmaceutical Factory set up Shenyang Shanzhinei Pharmaceutical Co., Ltd. in the form of a joint venture with a total investment of USD35.26 million and a total staff of 352. Harlem main production and operation, high